At the time of writing, Cytek BioSciences Inc [CTKB] stock is trading at $2.59, up 4.02%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CTKB shares have gain 4.44% over the last week, with a monthly amount drifted -30.93%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cytek BioSciences Inc [NASDAQ: CTKB] stock has seen the most recent analyst activity on May 09, 2025, when TD Cowen downgraded its rating to a Hold but kept the price target unchanged to $4 for it. Previously, Goldman downgraded its rating to Sell on January 31, 2025, and dropped its price target to $4.50. On December 14, 2023, Stephens initiated with a Overweight rating and assigned a price target of $9 on the stock. Raymond James started tracking the stock assigning a Mkt Perform rating.
For the past year, the stock price of Cytek BioSciences Inc fluctuated between $2.37 and $7.63. Currently, Wall Street analysts expect the stock to reach $6.63 within the next 12 months. Cytek BioSciences Inc [NASDAQ: CTKB] shares were valued at $2.59 at the most recent close of the market. An investor can expect a potential return of 155.98% based on the average CTKB price forecast.
Analyzing the CTKB fundamentals
According to Cytek BioSciences Inc [NASDAQ:CTKB], the company’s sales were 197.05M for trailing twelve months, which represents an -7.59% plunge. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at -0.13%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.03 and Total Capital is -0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.50 points at the first support level, and at 2.41 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.64, and for the 2nd resistance point, it is at 2.69.
Ratios To Look Out For
It is important to note that Cytek BioSciences Inc [NASDAQ:CTKB] has a current ratio of 5.62. In addition, the Quick Ratio stands at 4.95 and the Cash Ratio stands at 1.41. Considering the valuation of this stock, the price to sales ratio is 1.66, the price to book ratio is 0.87.
